Naomi Fisher, MD
Enriched profileDirector of hypertension services and hypertension innovation · Brigham and Women's Hospital
Naomi Fisher is Director of hypertension services and hypertension innovation at Brigham and Women's Hospital. OpenAlex indexes 187 publications with 8,351 citations (h-index 51); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 9 Nov 2026
Overview
Updated 20 Nov 2026
Naomi Fisher, MD, is Director of hypertension services and hypertension innovation at Brigham and Women's Hospital. The public record shows 187 publications with 8,351 citations (h-index 51), centered on Blood Pressure and Hypertension Studies, Renin-Angiotensin System Studies, Cardiovascular Health and Disease Prevention. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 7 companies, 6 NIH-funded awards (1998–2012).
- Most recent indexed publication: 2026 · Hypertension (Dallas, Tex.
- Top research focus: Blood Pressure and Hypertension Studies
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 20 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 14 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 97.
Clinical & industry
trials, payments and federal fundingContact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 9 Nov 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
- COOL-BP Study: Continuous Versus Occasional Blood Pressure Study
Sponsor: Aktiia SA
Industry payments
Updated 9 Nov 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Recor Medical IncProgram year202517 payments$18,411
- Boston Scientific CorporationProgram year20253 payments$6,033
- AstraZeneca UK LimitedProgram year20241 payment$1,611
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Calcium channel blocker32.3%Amlodipine Besylate70%Felodipine Er30%Part D<11 patientsAngiotensin receptor blocker (ARB)21.9%Irbesartan76%Olmesartan Medoxomil24%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 9 Nov 2026
6 NIH research awards on record, funded 1998–2012 per NIH RePORTER. The latest:
- Flavanol-Rich Cocoa, Vascular Responses and Mechanisms
Brigham and Women'S Hospital
FY2012$581,777R01HL089570 - Flavanol-Rich Cocoa, Vascular Responses and Mechanisms
Brigham and Women'S Hospital
FY2011$579,112R01HL089570 - Flavanol-Rich Cocoa, Vascular Responses and Mechanisms
Brigham and Women'S Hospital
FY2010$471,230R01HL089570
Congress activity
Updated 9 Nov 2026
8 congress contributions (2021–2026) across AHA, ESC, TCT (Transcatheter Cardiovascular Therapeutics) per OpenAlex. The most recent:
- Endovascular Arena Endovascular Arena 14: Endovascular Denervation — Novel Indications for Novel Locations
TCT (Transcatheter Cardiovascular Therapeutics)
TCT (Transcatheter Cardiovascular Therapeutics)2026Discussant - Endovascular Arena Endovascular Arena 1: Clinical Aspects of Performing RDN
TCT (Transcatheter Cardiovascular Therapeutics)
TCT (Transcatheter Cardiovascular Therapeutics)2026Session chair - Endovascular Arena Endovascular Arena 9: Renal Denervation in the Context of the Guidelines (2025 AHA Hypertension Guidelines, Japanese Guidelines, European Guidelines)
TCT (Transcatheter Cardiovascular Therapeutics)
TCT (Transcatheter Cardiovascular Therapeutics)2026Session chair
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles come from the meeting's own published program, matched through the same scorecard; a role we could not attribute with confidence is left off rather than guessed at.
Publications
Updated 9 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evaluating Patients for Renal Denervation: A Pragmatic Approach.
Hypertension (Dallas, Tex.
Article2026 - Renal Denervation to Treat Hypertension: A Clinical State-of-the-Art Review.
American journal of hypertension
Review2026 - Continual Versus Occasional Blood Pressure (COOL-BP) in Remote Hypertension Management.
American journal of hypertension
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humansArticle502 citations2003
- 03
- 04Pathways for Angiotensin II Generation in Intact Human TissueArticle336 citations1998
- 05Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in HumansArticle331 citations2010
Network
Updated 9 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 9 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
audioboom.com/posts/7695105
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →audioboom.com ↗ - Other
catalyst.harvard.edu/about/all-people/naomi-fisher-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →catalyst.harvard.edu ↗ - Other
radcliffecardiology.com/authors/naomi-fisher
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 9 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Pennsylvania
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →catalyst.harvard.edu ↗ - Bachelor's degree
Princeton University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →catalyst.harvard.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →catalyst.harvard.edu ↗
- Harvard UniversityverifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.harvard.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Reisa Sperling, MD
Brigham and Women's Hospital
Paul Ridker, MD
Brigham and Women's Hospital
George Mensah, MD
National Heart
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)